학술논문

CML-047 Post Hoc Analysis of Responses to Ponatinib in Patients With Chronic-Phase Chronic Myeloid Leukemia (CP-CML) by Baseline BCR::ABL1 Level and Baseline Mutation Status in the OPTIC Trial

Document Type

Article

Author

Deininger, M.; Apperley, J.; Arthur, C.K.; Chuah, C.; Hochhaus, A.; de Lavallade, H.; Lipton, J.; Lomaia, E.; McCloskey, J.; Maness, L.; Mauro, M.; Moraghi, B.; Pavlovsky, C.; Rosti, G.; Rousselot, P.; Sutton, M.U.; Ren, X.; Vorog, A.; Cortes, J.

Source

In: Clinical Lymphoma, Myeloma and Leukemia, Proceedings of the Society of Hematologic Oncology 2022 Annual Meeting. (Clinical Lymphoma, Myeloma and Leukemia, October 2022, 22:S285-S286)

Subject

Language

English

ISSN

21522669
21522650

Online Access

Full Text (ScienceDirect 종량제) Full Text (Clinical Key) Web of Science JCR 저널정보 Scopus Find it@PNU

이메일

부산대학교 도서관

Online Access

메일 발송